http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018092085-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_693e04867abb96f406e5344198cd264d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C337-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-175
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C337-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
filingDate 2017-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4232c9cd88a5832682242446e300c88e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_629ae22eb86019c578e831af0289fca9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15293e53cf559d77b51926073c60d911
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6307b2a766523ee4c9c9fd117a439d4f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38c555a2303d975400ed31b4b346563c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91f498451668592f04d0f3fbdbf5f29e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd565c4d390e82ea5d6450726c1e72ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40ea915cfeec302313f07bb7c560a652
publicationDate 2018-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2018092085-A1
titleOfInvention Pharmaceutical composition for treating tuberculosis
abstract The technical solution relates to the field of medicine, and particularly to means for treating tuberculosis. A pharmaceutical composition for treating tuberculosis contains an active ingredient and at least one pharmaceutically acceptable excipient, wherein the active ingredient contains a compound of formula I or a compound of formula II. The pharmaceutical composition based on novel active compounds exhibits activity in relation to bacteria that cause tuberculosis; in particular, said pharmaceutical composition exhibits antimycobacterial activity in relation to causative agents of tuberculosis that are resistant to at least one known anti-tuberculosis preparation.
priorityDate 2016-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009080432-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226513925
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19094

Total number of triples: 25.